ID

24346

Description

Study part: Dispensing Week 4.An Open-Label Extension phase 3 Study with REQUIP (ropinirole) CR for Subjects from Studies 101468/165, 101468/168 and 101468/169 Patient Level Data. Study ID:101468/248, Clinical Study ID: 101468/248.

Keywords

Versions (1)
  1. 7/30/17 7/30/17 -
Copyright Holder

GlaxoSmithKline

Uploaded on

July 30, 2017

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Dispensing Week 4 Ropinirole NCT00632736

English

Dispensing Week 4

1 forms  
  1. StudyEvent: ODM
    1. Dispensing Week 4
INVESTIGATIONAL PRODUCT
Description

INVESTIGATIONAL PRODUCT

Alias
UMLS CUI-1
C0304229
Record dispensing information in the lnvestigational Product section at the next visit.
Description

Investigational Product

Data type

boolean

Alias
UMLS CUI [1]
C0304229
Back to the top of the page

Similar models

Dispensing Week 4

1 forms
  1. StudyEvent: ODM
    1. Dispensing Week 4
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
INVESTIGATIONAL PRODUCT
C0304229 (UMLS CUI-1)
Investigational Product
Item
Record dispensing information in the lnvestigational Product section at the next visit.
boolean
C0304229 (UMLS CUI [1])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial